Achieve recognition of all radiotherapy professions
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney) - Read It Corner
Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy - Read It corner
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission - Read It Corner
Hypofractionated, 3-week, preoperative radiotherapy for patients with softæ tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial - Read It Corner
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study - Read It Corner
Retreatment of recurrent or second primary head and neck cancer after prior radiation: executive summary of the American Radium Society® (ARS) appropriate use criteria (AUC): expert panel on radiation oncology - head and neck cancer - Read It Corner
Corner Editor: Philippe Lambin
Corner Editor: Evert van Limbergen